News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Aleix Prat: Reveal Genomics Announces Positive Top-line Results for HER2DX in CLEOPATRA Phase III Trial
Photo taken from reveal-genomics.com
Sep 14, 2024, 09:48

Aleix Prat: Reveal Genomics Announces Positive Top-line Results for HER2DX in CLEOPATRA Phase III Trial

Aleix Prat, Director of Cancer Institute and Blood Disorders at Hospital Clínic de Barcelona, shared on LinkedIn:

 

“REVEAL GENOMICS Announces Positive Top-line Results for HER2DX in CLEOPATRA Phase III Trial

–HER2DX was evaluated in tumor samples from 214 patients with advanced HER2+ breast cancer treated with docetaxel, trastuzumab, and pertuzumab.
–The ERBB2 mRNA levels determined by HER2DX have shown a significant association with progression-free survival (PFS) and overall survival (OS).
–HER2DX is the world’s first diagnostic test formulated specifically for HER2+ breast cancer.”

Read Further.
Source: Aleix Prat/LinkedIn

 

Breast Cancer cancer docetaxel HER2+ breast cancer OncoDaily Oncology pertuzumab Reveal Genomics trastuzumab
Special Coverage
Insight
Nov 18, 2024, 20:54
Young patients with DIPG who respond well to the GD2 CAR-T cells
Insight
Nov 18, 2024, 20:51
Vivek Subbiah: Redefining pancreatic cancer management with tumor-agnostic precision medicine
Celebrities
Nov 18, 2024, 19:34
Rita Wilson - Tom Hank's Wife and Breast Cancer: How She Went Against, How She Survived, and More
Blog
Nov 18, 2024, 18:52
Integrative Medicine for Cancer-related Pain and Anxiety/Depression - Society for Integrative Oncology
Insight
Nov 18, 2024, 18:44
Talha Badar: Valuating co-mutations patterns of TP53-mutated myeloid neoplasms
Insight
Nov 18, 2024, 18:36
Uncovering mechanisms of immune evasion in Ovarian Cancer
Insight
Nov 18, 2024, 18:32
Molecular profiling of mBRAFV600E mCRC summarized by Arndt Vogel
Blog
Nov 18, 2024, 18:25
Sara Danielli: Grateful for being awarded with the Young Investigator Award from CTOS
Career
Nov 18, 2024, 18:06
Jason Westin is running for the Board of Directors of ASCO
Insight
Nov 18, 2024, 18:00
Common problem in GI oncology - NED in Non-Neuroendocrine Carcinoma
Blog
Nov 18, 2024, 17:46
John Christodouleas: 3 things I learned at the MR-Linac Consortium meeting in Singapore
Opinion
Nov 18, 2024, 17:40
Sebastian Bauer: We must not give up on MDM2 inhibitors in LPS